Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Sep;44(3):410–417. doi: 10.1038/bjc.1981.199

Characterization of a very-low-density lipoprotein (VLDL)-associated cytotoxic factor.

S Y Chan, M Pollard
PMCID: PMC2010784  PMID: 7284237

Abstract

A VLDL-associated cytotoxic factor was isolated from sera of pregnant rats and characterized. The inhibitory effect of this factor on the macromolecular synthesis of rat prostate adenocarcinoma cells (PA-III) was also examined. VLDL (Sf 20-400) was subfractionated by differential ultracentrifugal flotation and the Sf 100-400 fraction was associated with most of the oncolytic activity. Chemical analysis of serum VLDL at various stages of pregnancy indicated that the 4 major constituents of VLDL (protein, triglyceride, cholesterol, and phospholipid), and the cytotoxic titre, were increased significantly before parturition and restored to normal levels by 24 h post partum. The delipidation of lyophilized VLDL by n-heptane suggested that the cytotoxic component was associated with the neutral lipid core of VLDL. Kinetic studies of colony inhibition and the incorporation of radioactive thymidine and leucine into 10% TCA precipitates of PA-III cells showed that VLDL induced irreparable cellular damage during the initial 15 h of incubation. The cytotoxic activity of VLDL was not due to the association with PGF2 alpha, beta-oestradiol, progesterone, 25-hydroxycholesterol, or free fatty acids (oleic, stearic, palmitic, linoleic, linolenic and arachidonic acids), monopalmitolein, elaidyl and alpha-linolenyl alcohol. The role of this factor in host defence against neoplasia is discussed.

Full text

PDF
410

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  2. Apffel C. A. Nonimmunological host defenses: a review. Cancer Res. 1976 May;36(5):1527–1537. [PubMed] [Google Scholar]
  3. BARCLAY M., CALATHES D. N., GARFINKEL E., TEREBUSKEKISH O., BARCLAY R. K., SKIPSKI V. P. Low-density lipoproteins and lipoprotein lipase activity in tissues from rats bearing Walker carcinosarcoma 256. Arch Biochem Biophys. 1962 Sep;98:391–396. doi: 10.1016/0003-9861(62)90203-5. [DOI] [PubMed] [Google Scholar]
  4. Barclay M., Skipski V. P. Lipoproteins in relation to cancer. Prog Biochem Pharmacol. 1975;10:76–111. [PubMed] [Google Scholar]
  5. Barclay M., Skipski V. P., Terebus-Kekish O., Merker P. L., Cappuccino J. G. Serum lipoproteins in rats with tumors induced by 9,10-dimethyl-1,2-benzanthracene and with transplanted Walker carcinosarcoma 256. Cancer Res. 1967 Jun;27(6):1158–1167. [PubMed] [Google Scholar]
  6. Biggs H. G., Erikson J. M., Moorehead W. R. A manual colormetric assay of triglycerides in serum. Clin Chem. 1975 Mar;21(3):437–441. [PubMed] [Google Scholar]
  7. Chan S. Y. Androgen and glucocorticoid receptors in the Pollard prostate adenocarcinoma cell lines. Prostate. 1980;1(1):53–60. doi: 10.1002/pros.2990010108. [DOI] [PubMed] [Google Scholar]
  8. Chan S. Y., Pollard M. In vitro effects of lipoprotein-associated cytotoxic factor on rat prostate adenocarcinoma cells. Cancer Res. 1978 Sep;38(9):2956–2961. [PubMed] [Google Scholar]
  9. Chan S. Y., Pollard M. Metastasis-enhancing effect of heparin and its relationship to a lipoprotein factor. J Natl Cancer Inst. 1980 May;64(5):1121–1125. [PubMed] [Google Scholar]
  10. Chang C. F., Pollard M. In vitro propagation of prostate adenocarcinoma cells from rats. Invest Urol. 1977 Mar;14(5):331–334. [PubMed] [Google Scholar]
  11. Chapman H. A., Jr, Hibbs J. B., Jr Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science. 1977 Jul 15;197(4300):282–285. doi: 10.1126/science.195338. [DOI] [PubMed] [Google Scholar]
  12. Curtiss L. K., Edgington T. S. Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. J Immunol. 1977 Jun;118(6):1966–1970. [PubMed] [Google Scholar]
  13. Curtiss L. K., Edgington T. S. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol. 1976 May;116(5):1452–1458. [PubMed] [Google Scholar]
  14. Freeman C. P., West D. Complete separation of lipid classes on a single thin-layer plate. J Lipid Res. 1966 Mar;7(2):324–327. [PubMed] [Google Scholar]
  15. GUSTAFSON A., ALAUPOVIC P., FURMAN R. H. STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM. Biochemistry. 1965 Mar;4:596–605. doi: 10.1021/bi00879a033. [DOI] [PubMed] [Google Scholar]
  16. Goldstein J. L., Brown M. S. Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism. 1977 Nov;26(11):1257–1275. doi: 10.1016/0026-0495(77)90119-6. [DOI] [PubMed] [Google Scholar]
  17. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  18. Hui D. Y., Harmony J. A., Innerarity T. L., Mahley R. W. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B. J Biol Chem. 1980 Dec 25;255(24):11775–11781. [PubMed] [Google Scholar]
  19. Kandutsch A. A., Chen H. W. Consequences of blocked sterol synthesis in cultured cells. DNA synthesis and membrane composition. J Biol Chem. 1977 Jan 25;252(2):409–415. [PubMed] [Google Scholar]
  20. Kandutsch A. A., Chen H. W., Heiniger H. J. Biological activity of some oxygenated sterols. Science. 1978 Aug 11;201(4355):498–501. doi: 10.1126/science.663671. [DOI] [PubMed] [Google Scholar]
  21. Kane J. P., Hardman D. A., Dimpfl J. C., Levy J. A. Apolipoprotein is responsible for neutralization of xenotropic type C virus by mouse serum. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5957–5961. doi: 10.1073/pnas.76.11.5957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Leong J. C., Kane J. P., Oleszko O., Levy J. A. Antigen-specific nonimmunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proc Natl Acad Sci U S A. 1977 Jan;74(1):276–280. doi: 10.1073/pnas.74.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mortensen B. T., Knudtzon S., Schultz H. Serum lipoprotein inhibitors of granulopoiesis in human bone marrow cultures. Exp Hematol. 1979 Jan;7(1):1–10. [PubMed] [Google Scholar]
  24. Pollard M., Luckert P. H. Patterns of spontaneous metastasis manifested by three rat prostate adenocarcinomas. J Surg Oncol. 1979 Dec;12(4):371–377. doi: 10.1002/jso.2930120412. [DOI] [PubMed] [Google Scholar]
  25. Prehn R. T. Immunostimulation of the lymphodependent phase of neoplastic growth. J Natl Cancer Inst. 1977 Oct;59(4):1043–1049. doi: 10.1093/jnci/59.4.1043. [DOI] [PubMed] [Google Scholar]
  26. REJNEK J., BEDNARIK T., RERABKOVA E., DOLEZAL A. Investigations of the influence of sera from pregnant women on the growth of cell cultures in conjunction with the occurrence of abnormal alpha-lipoprotein. Clin Chim Acta. 1963 Jan;8:108–115. doi: 10.1016/0009-8981(63)90205-5. [DOI] [PubMed] [Google Scholar]
  27. Rifkin M. R. Identification of the trypanocidal factor in normal human serum: high density lipoprotein. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3450–3454. doi: 10.1073/pnas.75.7.3450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shortridge K. F., Ho W. K. Human serum lipoproteins as inhibitors of haemagglutination for selected togaviruses. J Gen Virol. 1974 Apr;23(1):113–116. doi: 10.1099/0022-1317-23-1-113. [DOI] [PubMed] [Google Scholar]
  29. Strauss J. F., 3rd, Seifter E., Lien E. L., Goodman D. B., Stambaugh R. L. Lipid metabolism in regressing rat corpora lutea of pregnancy. J Lipid Res. 1977 Mar;18(2):246–258. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES